Profile
ADMP ZTS TAK HLN TEVA ITCI
Company Name Adamis Pharmaceuticals Corporation Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Intra-Cellular Therapies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $7.25M $67.47B $45.57B $44.51B $18.42B $14.05B
Employees 0.01K 13.80K 49.28K 24.56K 37.00K 0.86K
CEO Ebrahim Versi Kristin C. Peck Christophe Weber Brian James McNamara Richard D. Francis Sharon Mates
Ratings
ADMP ZTS TAK HLN TEVA ITCI
Quant Rating Score 3 3 3 3 2 1
Quant Rating Neutral Neutral Neutral Neutral Sell Strong Sell
Trading
ADMP ZTS TAK HLN TEVA ITCI
Last Close $0.775 $148.6 $14.43 $9.6 $16.06 $131.87
High 52 $0.78 $196.48 $15.46 $11.41 $22.77 $131.91
Low 52 $0.78 $144.45 $12.89 $8.84 $12.82 $71.19
Price vs. 52 Week High -0.64 % -24.37 % -6.66 % -15.86 % -29.47 % -0.03 %
Price vs. 52 Week Low -0.64 % 2.87 % 11.95 % 8.6 % 25.27 % 85.24 %
Total Return
ADMP ZTS TAK HLN TEVA ITCI
1 Month Return 0 % -5.45 % -2.3 % -7.78 % -5.25 % 0 %
3 Month Return 0 % -0.05 % -1.9 % -6.07 % 17.66 % 0 %
6 Month Return 0 % -10.42 % 11.69 % 3.9 % -26.73 % 4.49 %
9 Month Return 0 % -23.12 % 0.7 % -4.86 % -10.53 % 68.33 %
YTD Return 0 % -8.8 % 8.99 % 0.63 % -27.13 % 57.89 %
1 Year Return 0 % -16.79 % 8.01 % 7.74 % -4.46 % 76.16 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ADMP ZTS TAK HLN TEVA ITCI
Dividend Yield Percentage (TTM) - 1.23 % 4.52 % 0.01 % - -
Dividend Paid and Capex Coverage Ration (TTM) -38.07 % 2 % 1.65 % - 2.53 % -227.26 %
Dividend Per Share (TTM) - 1.86 % 196 % 0.05 % - -
Payout Ratio (TTM) - 32.25 % 280.28 % - - -
Profitability
ADMP ZTS TAK HLN TEVA ITCI
Gross Profit Margin TTM -30.1 % 70.2 % 54.7 % 61.52 % 49.17 % 91.63 %
Return on Assets TTM -239.68 % 17.86 % 0.76 % 4.2 % -3.35 % -5.46 %
Return on Equity TTM -208.97 % 51.32 % 1.48 % 8.73 % -21.38 % -7.4 %
Return on Capital Employed TTM 5388.72 % 32.08 % 3.75 % 7.74 % 1.59 % -10.05 %
Net Income Per EBT TTM 100.01 % 78.79 % 61.12 % 75.5 % 246.36 % 100.64 %
EBT Per Ebit TTM 104.54 % 92.99 % 40.08 % 86.58 % -120.28 % 63.57 %
EBIT Per Revenue TTM -526.88 % 37.01 % 9.62 % 19.64 % 2.61 % -17.15 %
Cash Flow To Debt Ratio TTM -7560.82 % 43.63 % 21.32 % - 7.47 % -430.93 %
Receivables Turnover TTM 4.38 6.82 6.32 5.9 4.91 4.09
Payables Turnover TTM 0.78 6.51 4.36 2.19 3.69 2.18
Inventory Turnover TTM 4.99 1.16 1.7 3.63 2.6 2.17
Fixed Asset Turnover TTM 296.05 % 253.65 % 232.78 % 584.75 % 332.7 % 4569.25 %
Asset Turnover TTM 43.51 % 65.87 % 32.15 % 32.73 % 43.25 % 49.79 %
Operating Cash Flow Per Share TTM -12.1 6.58 608.55 - 1.11 -0.71
Free Cash Flow Per Share TTM -12.42 5.1 443.26 - 0.67 -0.71
Cash Per Share TTM 50.51 % 384.5 % 24349.44 % 24.05 % 149.12 % 970.67 %
Operating Cash Flow Sales Ratio TTM -544.58 % 31.71 % 21.01 % - 7.62 % -10.75 %
Free Cash Flow Operating Cash Flow Ratio TTM 102.63 % 77.45 % 72.84 % - 60.43 % 100.44 %
Cash Flow Coverage Ratios TTM -7560.82 % 43.63 % 21.32 % - 7.47 % -430.93 %
Price To Free Cash Flows Ratio TTM -0.27 29.58 9.74 - 24.3 -191.12
Price To Operating Cash Flows Ratio TTM -0.06 23.03 7.13 - 14.57 -185.85
Price Cash Flow Ratio TTM -0.06 23.03 7.13 - 14.57 -185.85
Income Statement (TTM)
ADMP ZTS TAK HLN TEVA ITCI
Revenue $0B $9.26B $4263.76B $11.23B
Gross Profit $-0B $6.54B $2832.26B $6.95B
Gross Profit Ratio -30.1% 70.62% 66.43% 61.85%
EBITDA $-0.02B $3.87B $874.6B $2.51B
Net Income $-0.03B $2.49B $144.07B $1.44B
EPS Diluted -12.24 5.47 45.58 0.32
Balance Sheet (MRQ)
ADMP ZTS TAK HLN TEVA ITCI
Long Term Debt $0B $5.39B $5029.93B $8.54B
Total Liabilities $0.01B $9.47B $7834.79B $18.09B
Total Equity $-0B $4.77B $7274.01B $16.22B
Total Investments $0B $0B $445.7B $0.08B
Total Debt $0B $6.74B $4843.75B $10.1B
Total Assets $0.01B $14.24B $15108.79B $34.32B
Cash Flow Statement (TTM)
ADMP ZTS TAK HLN TEVA ITCI
Net Income $-0.03B $2.5B $144.07B
Inventory $-0B $-0.04B $-115.74B
Dividends Paid $0B $-0.79B $-287.19B
Operating Cash Flow $-0.03B $2.95B $716.34B
Capital Expenditure $-0B $-0.66B $-480.73B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.53
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.21
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 8.63
ALVOW Alvotech 1.65
AMPH Amphastar Pharmaceuticals, Inc. 20.62
AMRX Amneal Pharmaceuticals, Inc. 7.97
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 66.3
APUS Apimeds Pharmaceuticals US, Inc 1.77
AQST Aquestive Therapeutics, Inc. 4.2
ASRT Assertio Holdings, Inc. 0.673
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 10.83
AYTU Aytu BioPharma, Inc. 2.37
ETFs With Exposure to ADMP
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 309.09
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 137.38
Unlock